Stryker

Stryker OCF/Debt

The Operating Cash Flow to Debt Ratio of Stryker (SYK) as of Nov 1, 2026 is 31.81 %. In the previous year, Operating Cash Flow to Debt Ratio was 31.20 % — a change of 1.95% (higher).

OCF/Debt

31.81 %

YoY

1.95%

Last updated:

Operating Cash Flow to Debt Ratio of Stryker is 2025 31.81 % . Operating Cash Flow to Debt Ratio of Stryker was 2024 31.20 % . It decreases by 1.95% higher compared to the previous year.

The Stryker OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2018
26.47 USD
Jan 1, 2019
19.76 USD
Jan 1, 2020
23.42 USD
Jan 1, 2021
26.15 USD
Jan 1, 2022
20.11 USD
Jan 1, 2023
28.56 USD
Jan 1, 2024
31.20 USD
Jan 1, 2025
31.81 USD
The Stryker OCF/Debt history
YEAROCF/DebtYoY
31.81 %+1.95%
31.20 %+9.25%
28.56 %+42.00%
20.11 %-23.09%
26.15 %+11.64%
23.42 %+18.55%
19.76 %-25.37%
26.47 %+22.64%
21.59 %-22.06%
27.70 %+23.17%
22.49 %-49.87%
44.85 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stryker Stock analysis

What does Stryker do? Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stryker stock

Operating Cash Flow to Debt Ratio of Stryker is 31.81 % in 2025.

Operating Cash Flow to Debt Ratio of Stryker changed from 31.20 % to 31.81 %, representing a 1.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Stryker since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Stryker with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Stryker

All Key Metrics — Stryker